No retraction, correction or concern found when last checked on Oct 26, 2026.

Beneath the Skin: A Review of Current Trends and Future Prospects of Transdermal Drug Delivery Systems

Ahlam Zaid Alkilani, Jehad Nasereddin, Rania Hamed and 4 more

Pharmaceutics · 2022 · Review · CC BY

Abstract

The ideal drug delivery system has a bioavailability comparable to parenteral dosage forms but is as convenient and easy to use for the patient as oral solid dosage forms. In recent years, there has been increased interest in transdermal drug delivery (TDD) as a non-invasive delivery approach that is generally regarded as being easy to administer to more vulnerable age groups, such as paediatric and geriatric patients, while avoiding certain bioavailability concerns that arise from oral drug delivery due to poor absorbability and metabolism concerns. However, despite its many merits, TDD remains restricted to a select few drugs. The physiology of the skin poses a barrier against the feasible delivery of many drugs, limiting its applicability to only those drugs that possess physicochemical properties allowing them to be successfully delivered transdermally. Several techniques have been developed to enhance the transdermal permeability of drugs. Both chemical (e.g., thermal and mechanical) and passive (vesicle, nanoparticle, nanoemulsion, solid dispersion, and nanocrystal) techniques have been investigated to enhance the permeability of drug substances across the skin. Furthermore, hybrid approaches combining chemical penetration enhancement technologies with physical technologies are being intensively researched to improve the skin permeation of drug substances. This review aims to summarize recent trends in TDD approaches and discuss the merits and drawbacks of the various chemical, physical, and hybrid approaches currently being investigated for improving drug permeability across the skin.

References 332

1.
Sahoo D., Bandaru R., Samal S.K., Naik R., Kumar P., Kesharwani P., Dandela R., Kesharwani P., Taurin S., Greish K. Chapter 9—Oral drug delivery of nanomedicine. Theory and Applications of Nonparenteral Nanomedicines. 2021;181-207.
Not in our library
2.
He M., Zhu L., Yang N., Li H., Yang Q. Recent advances of oral film as platform for drug delivery. Int. J. Pharm. 2021;604:120759.
Not in our library10.1016/j.ijpharm.2021.120759
3.
Kaur G., Arora M., Ravi Kumar M.N.V. Oral Drug Delivery Technologies-A Decade of Developments. J. Pharmacol. Exp. Ther. 2019;370:529-543.
Not in our library10.1124/jpet.118.255828
4.
Raza A., Hayat U., Bilal M., Iqbal H.M.N., Wang J.-Y. Zein-based micro- and nano-constructs and biologically therapeutic cues with multi-functionalities for oral drug delivery systems. J. Drug Deliv. Sci. Technol. 2020;58:101818.
Not in our library10.1016/j.jddst.2020.101818
5.
Gulati N., Gupta H. Parenteral drug delivery: A review. Recent Pat. Drug Deliv. Formul. 2011;5:133-145.
Not in our library10.2174/187221111795471391
6.
Nagarsenkar M.S., Dhawan V.V., Adejare A. Chapter 29—Parenteral preparations. Remington (Twenty-third Edition). 2021;577-603.
Not in our library
7.
Pastore M.N., Kalia Y.N., Horstmann M., Roberts M.S. Transdermal patches: History, development and pharmacology. Br. J. Pharmacol. 2015;172:2179-2209.
Not in our library10.1111/bph.13059
8.
Prausnitz M.R., Langer R. Transdermal drug delivery. Nat. Biotechnol. 2008;26:1261-1268.
Not in our library10.1038/nbt.1504
9.
Sharma G., Alle M., Chakraborty C., Kim J.C. Strategies for transdermal drug delivery against bone disorders: A preclinical and clinical update. J. Control. Release. 2021;336:375-395.
Not in our library10.1016/j.jconrel.2021.06.035
10.
Recent advances in transdermal drug delivery systems: a review · 2021
No notice
11.
Jung J.H., Jin S.G. Microneedle for transdermal drug delivery: Current trends and fabrication. J. Pharm. Investig. 2021;51:503-517.
Not in our library10.1007/s40005-021-00512-4
12.
Khoury R., Rajamanickam J., Grossberg G.T. An update on the safety of current therapies for Alzheimer’s disease: Focus on rivastigmine. Ther. Adv. Drug Saf. 2018;9:171-178.
Not in our library10.1177/2042098617750555
13.
Tsuno N., Mori T., Ishikawa I., Bando N., Park H., Matsumoto Y., Mori I., Tanaka M., Hirano T., Nakamura Y. Efficacy of rivastigmine transdermal therapy on low food intake in patients with Alzheimer’s disease: The Attitude Towards Food Consumption in Alzheimer’s Disease Patients Revive with Rivastigmine Effects study. Geriatr. Gerontol. Int. 2019;19:571-576.
Not in our library10.1111/ggi.13644
14.
Transdermal Drug Delivery: Innovative Pharmaceutical Developments Based on Disruption of the Barrier Properties of the Stratum Corneum · 2015
No notice
15.
Bajaj S., Whiteman A., Brandner B. Transdermal drug delivery in pain management. Contin. Educ. Anaesth. Crit. Care Pain. 2011;11:39-43.
Not in our library10.1093/bjaceaccp/mkq054
16.
Abrams L.S., Skee D.M., Natarajan J., Wong F.A., Anderson G.D. Pharmacokinetics of a contraceptive patch (Evra/Ortho Evra) containing norelgestromin and ethinyloestradiol at four application sites. Br. J. Clin. Pharmacol. 2002;53:141-146.
Not in our library10.1046/j.0306-5251.2001.01532.x
17.
Frampton J.E. Rotigotine Transdermal Patch: A Review in Parkinson’s Disease. CNS Drugs. 2019;33:707-718.
Not in our library10.1007/s40263-019-00646-y
18.
Schaer D.H., Buff L.A., Katz R.J. Sustained antianginal efficacy of transdermal nitroglycerin patches using an overnight 10-hour nitrate-free interval. Am. J. Cardiol. 1988;61:46-50.
Not in our library10.1016/0002-9149(88)91302-1
19.
Vartan C.M. Buprenorphine Transdermal Patch: An Overview for Use in Chronic Pain. US Pharm. 2014;10:16.
Not in our library
20.
Tanida N., Akiyama K., Terahara T. [Pharmacological profile and clinical efficacy of transdermal patch containing emedastine difumarate (ALLESAGA(®) TAPE)]. Nihon Yakurigaku Zasshi. Folia Pharmacol. Jpn. 2018;152:246-255.
Not in our library10.1254/fpj.152.246
21.
Birks J.S., Grimley Evans J. Rivastigmine for Alzheimer’s disease. Cochrane Database Syst. Rev. 2015;4:Cd001191.
Not in our library10.1002/14651858.cd001191.pub3
22.
Westhoff C.L., Reinecke I., Bangerter K., Merz M. Impact of body mass index on suppression of follicular development and ovulation using a transdermal patch containing 0.55-mg ethinyl estradiol/2.1-mg gestodene: A multicenter, open-label, uncontrolled study over three treatment cycles. Contraception. 2014;90:272-279.
Not in our library10.1016/j.contraception.2014.04.018
23.
Yousef H., Alhajj M., Sharma S. Anatomy, Skin (Integument), Epidermis. 2022.
Not in our library
24.
Kahraman E., Kaykın M., Şahin Bektay H., Güngör S. Recent Advances on Topical Application of Ceramides to Restore Barrier Function of Skin. Cosmetics. 2019;6:52.
Not in our library10.3390/cosmetics6030052
25.
Bouwstra J.A., Groenink H.W.W., Kempenaar J.A., Romeijn S.G., Ponec M. Water Distribution and Natural Moisturizer Factor Content in Human Skin Equivalents Are Regulated by Environmental Relative Humidity. J. Investig. Dermatol. 2008;128:378-388.
Not in our library10.1038/sj.jid.5700994
26.
Lai-Cheong J.E., McGrath J.A. Structure and function of skin, hair and nails. Medicine. 2021;49:337-342.
Not in our library10.1016/j.mpmed.2021.03.001
27.
Al-Akayleh F., Adwan S., Khanfar M., Idkaidek N., Al-Remawi M. A Novel Eutectic-Based Transdermal Delivery System for Risperidone. AAPS PharmSciTech. 2020;22:4.
Not in our library10.1208/s12249-020-01844-4
28.
Richard C., Cassel S., Blanzat M. Vesicular systems for dermal and transdermal drug delivery. RSC Adv. 2021;11:442-451.
Not in our library10.1039/d0ra09561c
29.
Moronkeji K., Todd S., Dawidowska I., Barrett S.D., Akhtar R. The role of subcutaneous tissue stiffness on microneedle performance in a representative in vitro model of skin. J. Control. Release. 2017;265:102-112.
Not in our library10.1016/j.jconrel.2016.11.004
30.
Karande P., Mitragotri S. Enhancement of transdermal drug delivery via synergistic action of chemicals. Biochim. et Biophys. Acta (BBA) Biomembr. 2009;1788:2362-2373.
Not in our library10.1016/j.bbamem.2009.08.015
31.
Alkilani A.Z., Alkalbani R., Jaber D., Hamed R., Hamad I., Abumansour H., Assab M.A. Knowledge, attitude, practice and satisfaction of patients using analgesic patches in Jordan. Trop. J. Pharm. Res. 2019;18:1745-1753.
Not in our library
32.
Berner B., John V.A. Pharmacokinetic Characterisation of Transdermal Delivery Systems. Clin. Pharmacokinet. 1994;26:121-134.
Not in our library10.2165/00003088-199426020-00005
33.
Parhi R., Mandru A. Enhancement of skin permeability with thermal ablation techniques: Concept to commercial products. Drug Deliv. Transl. Res. 2021;11:817-841.
Not in our library10.1007/s13346-020-00823-3
34.
Kurz A., Farlow M., Lefèvre G. Pharmacokinetics of a novel transdermal rivastigmine patch for the treatment of Alzheimer’s disease: A review. Int. J. Clin. Pract. 2009;63:799-805.
Not in our library10.1111/j.1742-1241.2009.02052.x
35.
Lane M.E. Skin penetration enhancers. Int. J. Pharm. 2013;447:12-21.
Not in our library10.1016/j.ijpharm.2013.02.040
36.
Hamed R., Al Baraghthi T., Alkilani A.Z., Abu-Huwaij R. Correlation between rheological properties and in vitro drug release from penetration enhancer-loaded Carbopol® gels. J. Pharm. Innov. 2016;11:339-351.
Not in our library10.1007/s12247-016-9262-9
37.
Hao Y., Li W., Zhou X., Yang F., Qian Z. Microneedles-based transdermal drug delivery systems: A review. J. Biomed. Nanotechnol. 2017;13:1581-1597.
Not in our library10.1166/jbn.2017.2474
38.
Enhancement strategies for transdermal drug delivery systems: current trends and applications · 2021
No notice
39.
Akhtar N., Singh V., Yusuf M., Khan R.A. Non-invasive drug delivery technology: Development and current status of transdermal drug delivery devices, techniques and biomedical applications. Biomed. Eng./Biomed. Tech. 2020;65:243-272.
Not in our library10.1515/bmt-2019-0019
40.
Subedi R.K., Oh S.Y., Chun M.-K., Choi H.-K. Recent advances in transdermal drug delivery. Arch. Pharmacal Res. 2010;33:339-351.
Not in our library10.1007/s12272-010-0301-7
41.
Lee J.W., Park J.-H., Prausnitz M.R. Dissolving microneedles for transdermal drug delivery. Biomaterials. 2008;29:2113-2124.
Not in our library10.1016/j.biomaterials.2007.12.048
42.
Finnin B.C., Morgan T.M. Transdermal penetration enhancers: Applications, limitations, and potential. J. Pharm. Sci. 1999;88:955-958.
Not in our library10.1021/js990154g
43.
Arora A., Prausnitz M.R., Mitragotri S. Micro-scale devices for transdermal drug delivery. Int. J. Pharm. 2008;364:227-236.
Not in our library10.1016/j.ijpharm.2008.08.032
44.
Zorec B., Préat V., Miklavčič D., Pavšelj N. Active enhancement methods for intra-and transdermal drug delivery: A review. Slov. Med. J. 2013;82:5.
Not in our library
45.
Kling J., DeFrancesco L. The paper trail to commercialization. Nat. Biotechnol. 2007;25:1217.
Not in our library10.1038/nbt1107-1217a
46.
Karande P., Jain A., Mitragotri S. Discovery of transdermal penetration enhancers by high-throughput screening. Nat. Biotechnol. 2004;22:192-197.
Not in our library10.1038/nbt928
47.
Bozdaganyan M.E., Orekhov P.S. Synergistic Effect of Chemical Penetration Enhancers on Lidocaine Permeability Revealed by Coarse-Grained Molecular Dynamics Simulations. Membranes. 2021;11:410.
Not in our library10.3390/membranes11060410
48.
Cho C.W., Shin S.C. Enhanced transdermal delivery of atenolol from the ethylene-vinyl acetate matrix. Int. J. Pharm. 2004;287:67-71.
Not in our library10.1016/j.ijpharm.2004.08.013
49.
Dragicevic N., Maibach H.I. Percutaneous Penetration Enhancers Physical Methods in Penetration Enhancement. 2017.
Not in our library
50.
Kanikkannan N., Singh M. Skin permeation enhancement effect and skin irritation of saturated fatty alcohols. Int. J. Pharm. 2002;248:219-228.
Not in our library10.1016/s0378-5173(02)00454-4
51.
Maibach H.I., Feldmann R.J. The effect of DMSO on percutaneous penetration of hydrocortisone and testosterone in man. Ann. N. Y. Acad. Sci. 1967;141:423-427.
Not in our library10.1111/j.1749-6632.1967.tb34906.x
52.
Hadgraft J., Lane M.E. Transdermal delivery of testosterone. Eur. J. Pharm. Biopharm. 2015;92:42-48.
Not in our library10.1016/j.ejpb.2015.02.015
53.
Jaiswal J., Poduri R., Panchagnula R. Transdermal delivery of naloxone: Ex vivo permeation studies. Int. J. Pharm. 1999;179:129-134.
Not in our library10.1016/s0378-5173(98)00383-4
54.
Liu C., Guan Y., Tian Q., Shi X., Fang L. Transdermal enhancement strategy of ketoprofen and teriflunomide: The effect of enhanced drug-drug intermolecular interaction by permeation enhancer on drug release of compound transdermal patch. Int. J. Pharm. 2019;572:118800.
Not in our library10.1016/j.ijpharm.2019.118800
55.
Ameen D., Michniak-Kohn B. Transdermal delivery of dimethyl fumarate for Alzheimer’s disease: Effect of penetration enhancers. Int. J. Pharm. 2017;529:465-473.
Not in our library10.1016/j.ijpharm.2017.07.031
56.
Singh B.N., Singh R.B., Singh J. Effects of ionization and penetration enhancers on the transdermal delivery of 5-fluorouracil through excised human stratum corneum. Int. J. Pharm. 2005;298:98-107.
Not in our library10.1016/j.ijpharm.2005.04.004
57.
Lee P.J., Langer R., Shastri V.P. Role of n-methyl pyrrolidone in the enhancement of aqueous phase transdermal transport. J. Pharm. Sci. 2005;94:912-917.
Not in our library10.1002/jps.20291
58.
Ogiso T., Hata T., Iwaki M., TANINO T. Transdermal absorption of bupranolol in rabbit skin in vitro and in vivo. Biol. Pharm. Bull. 2001;24:588-591.
Not in our library10.1248/bpb.24.588
59.
Van Zyl L., Du Preez J., Gerber M., Du Plessis J., Viljoen J. Essential fatty acids as transdermal penetration enhancers. J. Pharm. Sci. 2016;105:188-193.
Not in our library10.1016/j.xphs.2015.11.032
60.
Stott P.W., Williams A.C., Barry B.W. Mechanistic study into the enhanced transdermal permeation of a model β-blocker, propranolol, by fatty acids: A melting point depression effect. Int. J. Pharm. 2001;219:161-176.
Not in our library10.1016/s0378-5173(01)00645-7
61.
Klimentová J., Kosák P., Vávrová K., Holas T., Hrabálek A. Influence of terminal branching on the transdermal permeation-enhancing activity in fatty alcohols and acids. Bioorganic Med. Chem. 2006;14:7681-7687.
Not in our library10.1016/j.bmc.2006.08.013
62.
Melero A., Garrigues T., Almudever P., Martı A., Lehr C., Schäfer U. Nortriptyline hydrochloride skin absorption: Development of a transdermal patch. Eur. J. Pharm. Biopharm. 2008;69:588-596.
Not in our library10.1016/j.ejpb.2007.11.012
63.
Haq A., Michniak-Kohn B. Effects of solvents and penetration enhancers on transdermal delivery of thymoquinone: Permeability and skin deposition study. Drug Deliv. 2018;25:1943-1949.
Not in our library10.1080/10717544.2018.1523256
64.
Stahl J., Kietzmann M. The effects of chemical and physical penetration enhancers on the percutaneous permeation of lidocaine through equine skin. BMC Vet. Res. 2014;10:1-6.
Not in our library10.1186/1746-6148-10-138
65.
Ogiso T., Iwaki M., Paku T. Effect of various enhancers on transdermal penetration of indomethacin and urea, and relationship between penetration parameters and enhancement factors. J. Pharm. Sci. 1995;84:482-488.
Not in our library10.1002/jps.2600840418
66.
Vijaya C., Bingi M., Vigneshwaran L. Transdermal delivery of venlafaxine hydrochloride: The effects of enhancers on permeation across pig ear skin. Indian J. Pharm. Sci. 2011;73:456.
Not in our library10.4103/0250-474x.95650
67.
Björklund S., Engblom J., Thuresson K., Sparr E. Glycerol and urea can be used to increase skin permeability in reduced hydration conditions. Eur. J. Pharm. Sci. 2013;50:638-645.
Not in our library10.1016/j.ejps.2013.04.022
68.
Narishetty S.T.K., Panchagnula R. Transdermal delivery of zidovudine: Effect of terpenes and their mechanism of action. J. Control. Release. 2004;95:367-379.
Not in our library10.1016/j.jconrel.2003.11.022
69.
Jain A.K., Thomas N.S., Panchagnula R. Transdermal drug delivery of imipramine hydrochloride.: I. Effect of terpenes. J. Control. Release. 2002;79:93-101.
Not in our library10.1016/s0168-3659(01)00524-7
70.
Nokhodchi A., Shokri J., Dashbolaghi A., Hassan-Zadeh D., Ghafourian T., Barzegar-Jalali M. The enhancement effect of surfactants on the penetration of lorazepam through rat skin. Int. J. Pharm. 2003;250:359-369.
Not in our library10.1016/s0378-5173(02)00554-9
71.
Piret J., Désormeaux A., Cormier H., Lamontagne J., Gourde P., Juhász J., Bergeron M.G. Sodium lauryl sulfate increases the efficacy of a topical formulation of foscarnet against herpes simplex virus type 1 cutaneous lesions in mice. Antimicrob. Agents Chemother. 2000;44:2263-2270.
Not in our library10.1128/aac.44.9.2263-2270.2000
72.
Akhtar N., Rehman M., Khan H., Rasool F., Saeed T., Murtaz G. Penetration enhancing effect of polysorbate 20 and 80 on the in vitro percutaneous absorption of lascorbic acid. Trop. J. Pharm. Res. 2011;10:3.
Not in our library10.4314/tjpr.v10i3.1
73.
Abdulbaqi I.M., Darwis Y., Khan N.A., Assi R.A., Khan A.A. Ethosomal nanocarriers: The impact of constituents and formulation techniques on ethosomal properties, in vivo studies, and clinical trials. Int. J. Nanomed. 2016;11:2279-2304.
Not in our library10.2147/ijn.s105016
74.
Bhardwaj P., Tripathi P., Gupta R., Pandey S. Niosomes: A review on niosomal research in the last decade. J. Drug Deliv. Sci. Technol. 2020;56:101581.
Not in our library10.1016/j.jddst.2020.101581
75.
Bozzuto G., Molinari A. Liposomes as nanomedical devices. Int. J. Nanomed. 2015;10:975-999.
Not in our library10.2147/ijn.s68861
76.
Chacko I.A., Ghate V.M., Dsouza L., Lewis S.A. Lipid vesicles: A versatile drug delivery platform for dermal and transdermal applications. Colloids Surf. B Biointerfaces. 2020;195:111262.
Not in our library10.1016/j.colsurfb.2020.111262
77.
Babaie S., Bakhshayesh A.R.D., Ha J.W., Hamishehkar H., Kim K.H. Invasome: A Novel Nanocarrier for Transdermal Drug Delivery. Nanomaterials. 2020;10:341.
Not in our library10.3390/nano10020341
78.
Jain S., Jain V., Mahajan S.C. Lipid Based Vesicular Drug Delivery Systems. Adv. Pharm. 2014;2014:574673.
Not in our library10.1155/2014/574673
79.
Pandita A., Sharma P. Pharmacosomes: An emerging novel vesicular drug delivery system for poorly soluble synthetic and herbal drugs. ISRN Pharm. 2013;2013:348186.
Not in our library10.1155/2013/348186
80.
Witika B.A., Mweetwa L.L., Tshiamo K.O., Edler K., Matafwali S.K., Ntemi P.V., Chikukwa M.T.R., Makoni P.A. Vesicular drug delivery for the treatment of topical disorders: Current and future perspectives. J. Pharm. Pharmacol. 2021;73:1427-1441.
Not in our library10.1093/jpp/rgab082
81.
Elsharkasy O.M., Nordin J.Z., Hagey D.W., de Jong O.G., Schiffelers R.M., Andaloussi S.E.L., Vader P. Extracellular vesicles as drug delivery systems: Why and how? Adv. Drug Deliv. Rev. 2020;159:332-343.
Not in our library10.1016/j.addr.2020.04.004
82.
Liposomes: Structure, Biomedical Applications, and Stability Parameters With Emphasis on Cholesterol · 2021
Retracted
83.
Nayak D., Tippavajhala V.K. A Comprehensive Review on Preparation, Evaluation and Applications of Deformable Liposomes. Iran. J. Pharm. Res. 2021;20:186-205.
Not in our library10.22037/ijpr.2020.112878.13997
84.
Application of Various Types of Liposomes in Drug Delivery Systems · 2017
No notice
85.
Hussain A., Singh S., Sharma D., Webster T.J., Shafaat K., Faruk A. Elastic liposomes as novel carriers: Recent advances in drug delivery. Int. J. Nanomed. 2017;12:5087-5108.
Not in our library10.2147/ijn.s138267
86.
Ntimenou V., Fahr A., Antimisiaris S.G. Elastic vesicles for transdermal drug delivery of hydrophilic drugs: A comparison of important physicochemical characteristics of different vesicle types. J. Biomed. Nanotechnol. 2012;8:613-623.
Not in our library10.1166/jbn.2012.1426
87.
Romero E.L., Morilla M.J. Ultradeformable phospholipid vesicles as a drug delivery system: A review. Res. Rep. Transdermal Drug Deliv. 2015;4:55-69.
Not in our library10.2147/rrtd.s50370
88.
Sudhakar K., Fuloria S., Subramaniyan V., Sathasivam K.V., Azad A.K., Swain S.S., Sekar M., Karupiah S., Porwal O., Sahoo A., et al. Ultraflexible Liposome Nanocargo as a Dermal and Transdermal Drug Delivery System. Nanomaterials. 2021;11:2557.
Not in our library10.3390/nano11102557
89.
Rai S., Pandey V. Transfersomes as versatile and flexible nano-vesicular carriers in skin cancer therapy: The state of the art. Nano Rev. Exp. 2017;8:1325708.
Not in our library10.1080/20022727.2017.1325708
90.
Transfersomes: A Promising Nanoencapsulation Technique for Transdermal Drug Delivery · 2020
No notice
91.
Akram M.W., Jamshaid H., Rehman F.U., Zaeem M., Khan J.Z., Zeb A. Transfersomes: A Revolutionary Nanosystem for Efficient Transdermal Drug Delivery. AAPS PharmSciTech. 2021;23:7.
Not in our library10.1208/s12249-021-02166-9
92.
Duangjit S., Opanasopit P., Rojanarata T., Ngawhirunpat T. Characterization and In Vitro Skin Permeation of Meloxicam-Loaded Liposomes versus Transfersomes. J. Drug Deliv. 2011;2011:418316.
Not in our library10.1155/2011/418316
93.
Sardana V., Burzynski J., Zalzal P. Safety and efficacy of topical ketoprofen in transfersome gel in knee osteoarthritis: A systematic review. Musculoskelet. Care. 2017;15:114-121.
Not in our library10.1002/msc.1163
94.
Bnyan R., Khan I., Ehtezazi T., Saleem I., Gordon S., O’Neill F., Roberts M. Formulation and optimisation of novel transfersomes for sustained release of local anaesthetic. J. Pharm. Pharmacol. 2019;71:1508-1519.
Not in our library10.1111/jphp.13149
95.
Cevc G. Transdermal drug delivery of insulin with ultradeformable carriers. Clin. Pharmacokinet. 2003;42:461-474.
Not in our library10.2165/00003088-200342050-00004
96.
Cevc G., Blume G., Schätzlein A. Transfersomes-mediated transepidermal delivery improves the regio-specificity and biological activity of corticosteroids in vivo. J. Control. Release. 1997;45:211-226.
Not in our library10.1016/s0168-3659(96)01566-0
97.
Chen S., Hanning S., Falconer J., Locke M., Wen J. Recent advances in non-ionic surfactant vesicles (niosomes): Fabrication, characterization, pharmaceutical and cosmetic applications. Eur. J. Pharm. Biopharm. 2019;144:18-39.
Not in our library10.1016/j.ejpb.2019.08.015
98.
Khoee S., Yaghoobian M., Andronescu E., Grumezescu A.M. Chapter 6—Niosomes: A novel approach in modern drug delivery systems. Nanostructures for Drug Delivery. 2017;207-237.
Not in our library
99.
Masjedi M., Montahaei T. An illustrated review on nonionic surfactant vesicles (niosomes) as an approach in modern drug delivery: Fabrication, characterization, pharmaceutical, and cosmetic applications. J. Drug Deliv. Sci. Technol. 2021;61:102234.
Not in our library10.1016/j.jddst.2020.102234
100.
Durak S., Esmaeili Rad M., Alp Yetisgin A. Niosomal Drug Delivery Systems for Ocular Disease-Recent Advances and Future Prospects. Nanomaterials. 2020;10:1191.
Not in our library10.3390/nano10061191
101.
Advances of Non-Ionic Surfactant Vesicles (Niosomes) and Their Application in Drug Delivery · 2019
No notice
102.
Khan R., Irchhaiya R. Niosomes: A potential tool for novel drug delivery. J. Pharm. Investig. 2016;46:195-204.
Not in our library10.1007/s40005-016-0249-9
103.
El-Ridy M.S., Yehia S.A., Mohsen A.M., El-Awdan S.A., Darwish A.B. Formulation of Niosomal Gel for Enhanced Transdermal Lornoxicam Delivery: In-Vitro and In-Vivo Evaluation. Curr. Drug Deliv. 2018;15:122-133.
Not in our library10.2174/1567201814666170224141548
104.
Patel K.K., Kumar P., Thakkar H.P. Formulation of niosomal gel for enhanced transdermal lopinavir delivery and its comparative evaluation with ethosomal gel. AAPS PharmSciTech. 2012;13:1502-1510.
Not in our library10.1208/s12249-012-9871-7
105.
Honeywell-Nguyen P.L., Bouwstra J.A. The in vitro transport of pergolide from surfactant-based elastic vesicles through human skin: A suggested mechanism of action. J. Control. Release. 2003;86:145-156.
Not in our library10.1016/s0168-3659(02)00415-7
106.
El Maghraby G.M., Barry B.W., Williams A.C. Liposomes and skin: From drug delivery to model membranes. Eur. J. Pharm. Sci. Off. J. Eur. Fed. Pharm. Sci. 2008;34:203-222.
Not in our library10.1016/j.ejps.2008.05.002
107.
Benson H.A.E., Grice J.E., Mohammed Y., Namjoshi S., Roberts M.S. Topical and Transdermal Drug Delivery: From Simple Potions to Smart Technologies. Curr. Drug Deliv. 2019;16:444-460.
Not in our library10.2174/1567201816666190201143457
108.
Halnor V., Pande V., Borawake D., Nagare H. Nanoemulsion: A novel platform for drug delivery system. J. Mat. Sci. Nanotechol. 2018;6:104.
Not in our library
109.
Hamed R., Basil M., AlBaraghthi T., Sunoqrot S., Tarawneh O. Nanoemulsion-based gel formulation of diclofenac diethylamine: Design, optimization, rheological behavior and in vitro diffusion studies. Pharm. Dev. Technol. 2016;21:980-989.
Not in our library10.3109/10837450.2015.1086372
110.
Abu-Huwaij R., Al-Assaf S.F., Hamed R. Recent exploration of nanoemulsions for drugs and cosmeceuticals delivery. J. Cosmet. Dermatol. 2021.
Not in our library10.1111/jocd.14704
111.
McClements D.J. Nanoemulsions versus microemulsions: Terminology, differences, and similarities. Soft Matter. 2012;8:1719-1729.
Not in our library10.1039/c2sm06903b
112.
Hamed R., Al-Adhami Y., Abu-Huwaij R. Concentration of a microemulsion influences the mechanical properties of ibuprofen in situ microgels. Int. J. Pharm. 2019;570:118684.
Not in our library10.1016/j.ijpharm.2019.118684
113.
Hamed R., Farhan A., Abu-Huwaij R., Mahmoud N.N., Kamal A. Lidocaine microemulsion-laden organogels as lipid-based systems for topical delivery. J. Pharm. Innov. 2019;15:1-14.
Not in our library10.1007/s12247-019-09399-z
114.
Ganesan P., Karthivashan G., Park S.Y., Kim J., Choi D.-K. Microfluidization trends in the development of nanodelivery systems and applications in chronic disease treatments. Int. J. Nanomed. 2018;13:6109.
Not in our library10.2147/ijn.s178077
115.
Qian C., McClements D.J. Formation of nanoemulsions stabilized by model food-grade emulsifiers using high-pressure homogenization: Factors affecting particle size. Food Hydrocoll. 2011;25:1000-1008.
Not in our library10.1016/j.foodhyd.2010.09.017
116.
Hashtjin A.M., Abbasi S. Nano-emulsification of orange peel essential oil using sonication and native gums. Food Hydrocoll. 2015;44:40-48.
Not in our library10.1016/j.foodhyd.2014.08.017
117.
Liu W., Sun D., Li C., Liu Q., Xu J. Formation and stability of paraffin oil-in-water nano-emulsions prepared by the emulsion inversion point method. J. Colloid Interface Sci. 2006;303:557-563.
Not in our library10.1016/j.jcis.2006.07.055
118.
Izquierdo P., Esquena J., Tadros T.F., Dederen C., Garcia M., Azemar N., Solans C. Formation and stability of nano-emulsions prepared using the phase inversion temperature method. Langmuir. 2002;18:26-30.
Not in our library10.1021/la010808c
119.
Azmi N.A.N., Elgharbawy A.A., Motlagh S.R., Samsudin N., Salleh H.M. Nanoemulsions: Factory for Food, Pharmaceutical and Cosmetics. Processes. 2019;7:617.
Not in our library10.3390/pr7090617
120.
Devarajan V., Ravichandran V. Nanoemulsions: As modified drug delivery tool. Int. J. Compr. Pharm. 2011;2:1-6.
Not in our library
121.
Chavda V.P., Shah D. A review on novel emulsification technique: A nanoemulsion. J. Pharmacol. Toxicol. Stud. 2017;5:32-33.
Not in our library
122.
Sutradhar K.B., Amin M.L. Nanoemulsions: Increasing possibilities in drug delivery. Eur. J. Nanomed. 2013;5:97-110.
Not in our library10.1515/ejnm-2013-0001
123.
Hamed R., Mahmoud N.N., Alnadi S.H., Alkilani A.Z., Hussein G. Diclofenac diethylamine nanosystems-loaded bigels for topical delivery: Development, rheological characterization, and release studies. Drug Dev. Ind. Pharm. 2020;46:1705-1715.
Not in our library10.1080/03639045.2020.1820038
124.
Koroleva M., Nagovitsina T., Yurtov E. Nanoemulsions stabilized by non-ionic surfactants: Stability and degradation mechanisms. Phys. Chem. Chem. Phys. 2018;20:10369-10377.
Not in our library10.1039/c7cp07626f
125.
Fernandes A.R., Sanchez-Lopez E., Santos T.d., Garcia M.L., Silva A.M., Souto E.B. Development and Characterization of Nanoemulsions for Ophthalmic Applications: Role of Cationic Surfactants. Materials. 2021;14:7541.
Not in our library10.3390/ma14247541
126.
Fraga M., de Carvalho T.G., da Silva Diel D., Bruxel F., Teixeira H.F., Matte U. Cationic nanoemulsions as a gene delivery system: Proof of concept in the mucopolysaccharidosis I murine model. J. Nanosci. Nanotechnol. 2015;15:810-816.
Not in our library10.1166/jnn.2015.9179
127.
Kundu P., Agrawal A., Mateen H., Mishra I.M. Stability of oil-in-water macro-emulsion with anionic surfactant: Effect of electrolytes and temperature. Chem. Eng. Sci. 2013;102:176-185.
Not in our library10.1016/j.ces.2013.07.050
128.
Ribeiro R.C.d.A., Barreto S.M.A.G., Ostrosky E.A., Rocha-Filho P.A.d., Veríssimo L.M., Ferrari M. Production and characterization of cosmetic nanoemulsions containing Opuntia ficus-indica (L.) Mill extract as moisturizing agent. Molecules. 2015;20:2492-2509.
Not in our library10.3390/molecules20022492
129.
Hamed R., Seder B.Y., Bardaweel S.K., Qawass H. Lipid-based formulations of microemulsion-loaded oleogels for the oral delivery of carvedilol. J. Dispers. Sci. Technol. 2021;1-11.
Not in our library10.1080/01932691.2021.1964987
130.
Praveen Kumar G., Divya A. Nanoemulsion based targeting in cancer therapeutics. Med. Chem. 2015;5:272-284.
Not in our library10.4172/2161-0444.1000275
131.
Lovelyn C., Attama A.A. Current state of nanoemulsions in drug delivery. J. Biomater. Nanobiotechnol. 2011;2:626.
Not in our library10.4236/jbnb.2011.225075
132.
Shaker D.S., Ishak R.A., Ghoneim A., Elhuoni M.A. Nanoemulsion: A review on mechanisms for the transdermal delivery of hydrophobic and hydrophilic drugs. Sci. Pharm. 2019;87:17.
Not in our library10.3390/scipharm87030017
133.
Zaid Alkilani A., Hamed R., Hussein G., Alnadi S. Nanoemulsion-based patch for the dermal delivery of ascorbic acid. J. Dispers. Sci. Technol. 2021;1-11.
Not in our library10.1080/01932691.2021.1880924
134.
Zhengguang L., Jie H., Yong Z., Jiaojiao C., Xingqi W., Xiaoqin C. Study on the transdermal penetration mechanism of ibuprofen nanoemulsions. Drug Dev. Ind. Pharm. 2019;45:465-473.
Not in our library10.1080/03639045.2018.1546317
135.
Shakeel F., Baboota S., Ahuja A., Ali J., Aqil M., Shafiq S. Nanoemulsions as vehicles for transdermal delivery of aceclofenac. AAPS PharmSciTech. 2007;8:191-199.
Not in our library10.1208/pt0804104
136.
Pathan I., Mangle M., Bairagi S. Design and characterization of nanoemulsion for transdermal delivery of meloxicam. Anal. Chem. Lett. 2016;6:286-295.
Not in our library10.1080/22297928.2016.1209126
137.
Khurana S., Jain N., Bedi P. Nanoemulsion based gel for transdermal delivery of meloxicam: Physico-chemical, mechanistic investigation. Life Sci. 2013;92:383-392.
Not in our library10.1016/j.lfs.2013.01.005
138.
Shakeel F., Baboota S., Ahuja A., Ali J., Shafiq S. Skin permeation mechanism and bioavailability enhancement of celecoxib from transdermally applied nanoemulsion. J. Nanobiotechnol. 2008;6:1-11.
Not in our library10.1186/1477-3155-6-8
139.
Shakeel F., Baboota S., Ahuja A., Ali J., Shafiq S. Celecoxib nanoemulsion for transdermal drug delivery: Characterization and in vitro evaluation. J. Dispers. Sci. Technol. 2009;30:834-842.
Not in our library10.1080/01932690802644012
140.
Kim B.S., Won M., Yang, Lee K.M., Kim C.S. In vitro permeation studies of nanoemulsions containing ketoprofen as a model drug. Drug Deliv. 2008;15:465-469.
Not in our library10.1080/10717540802328599
141.
Arora R., Aggarwal G., Harikumar S., Kaur K. Nanoemulsion based hydrogel for enhanced transdermal delivery of ketoprofen. Adv. Pharm. 2014;2014.
Not in our library10.1155/2014/468456
142.
Barakat N., Fouad E., Elmedany A. Formulation design of indomethacin-loaded nanoemulsion for transdermal delivery. Pharm. Anal. Acta. 2011;2:1-8.
Not in our library10.4172/2153-2435.s2-002
143.
El-Leithy E.S., Ibrahim H.K., Sorour R.M. In vitro and in vivo evaluation of indomethacin nanoemulsion as a transdermal delivery system. Drug Deliv. 2015;22:1010-1017.
Not in our library10.3109/10717544.2013.844742
144.
Shakeel F., Ramadan W., Ahmed M.A. Investigation of true nanoemulsions for transdermal potential of indomethacin: Characterization, rheological characteristics, and ex vivo skin permeation studies. J. Drug Target. 2009;17:435-441.
Not in our library10.1080/10611860902963021
145.
Dhawan B., Aggarwal G., Harikumar S. Enhanced transdermal permeability of piroxicam through novel nanoemulgel formulation. Int. J. Pharm. Investig. 2014;4:65.
Not in our library10.4103/2230-973x.133053
146.
Kumar D., Ali J., Baboota S. Omega 3 fatty acid-enriched nanoemulsion of thiocolchicoside for transdermal delivery: Formulation, characterization and absorption studies. Drug Deliv. 2016;23:591-600.
Not in our library10.3109/10717544.2014.916764
147.
Pratap S.B., Brajesh K., Jain S., Kausar S. Development and characterization of a nanoemulsion gel formulation for transdermal delivery of carvedilol. Int. J. Drug Dev. Res. 2012;4:151-161.
Not in our library
148.
Alkilani A.Z., Hamed R., Al-Marabeh S., Kamal A., Abu-Huwaij R., Hamad I. Nanoemulsion-based film formulation for transdermal delivery of carvedilol. J. Drug Deliv. Sci. Tec. 2018;46:122-128.
Not in our library10.1016/j.jddst.2018.05.015
149.
Aqil M., Kamran M., Ahad A., Imam S.S. Development of clove oil based nanoemulsion of olmesartan for transdermal delivery: Box–Behnken design optimization and pharmacokinetic evaluation. J. Mol. Liq. 2016;214:238-248.
Not in our library10.1016/j.molliq.2015.12.077
150.
Sharma A., Singh A., Harikumar S. Development and optimization of nanoemulsion based gel for enhanced transdermal delivery of nitrendipine using box-behnken statistical design. Drug Dev. Ind. Pharm. 2020;46:329-342.
Not in our library10.1080/03639045.2020.1721527
151.
Shakeel F., Ramadan W. Transdermal delivery of anticancer drug caffeine from water-in-oil nanoemulsions. Colloids Surf. B Biointerfaces. 2010;75:356-362.
Not in our library10.1016/j.colsurfb.2009.09.010
152.
Tsai M.-J., Fu Y.-S., Lin Y.-H., Huang Y.-B., Wu P.-C. The effect of nanoemulsion as a carrier of hydrophilic compound for transdermal delivery. PLoS ONE. 2014;9:e102850.
Not in our library10.1371/journal.pone.0102850
153.
Wu H., Ramachandran C., Weiner N.D., Roessler B.J. Topical transport of hydrophilic compounds using water-in-oil nanoemulsions. Int. J. Pharm. 2001;220:63-75.
Not in our library10.1016/s0378-5173(01)00671-8
154.
Harwansh R.K., Patra K.C., Pareta S.K., Singh J., Rahman M.A. Nanoemulsions as vehicles for transdermal delivery of glycyrrhizin. Braz. J. Pharm. Sci. 2011;47:769-778.
Not in our library10.1590/s1984-82502011000400014
155.
Ali M.S., Alam M.S., Alam N., Siddiqui M.R. Preparation, characterization and stability study of dutasteride loaded nanoemulsion for treatment of benign prostatic hypertrophy. Iran. J. Pharm. Res. 2014;13:1125.
Not in our library
156.
Pathan I.B., Mallikarjuna Setty C. Nanoemulsion system for transdermal delivery of tamoxifen citrate: design, characterization, effect of penetration enhancers and in vivo studies. Dig. J. Nanomater. Biostructures (DJNB). 2012;7:1373-1387.
Not in our library
157.
Zheng W.-W., Zhao L., Wei Y.-M., Ye Y., Xiao S.-H. Preparation and the in vitro evaluation of nanoemulsion system for the transdermal delivery of granisetron hydrochloride. Chem. Pharm. Bull. 2010;58:1015-1019.
Not in our library10.1248/cpb.58.1015
158.
Zheng Y., Ouyang W.-Q., Wei Y.-P., Syed S.F., Hao C.-S., Wang B.-Z., Shang Y.-H. Effects of Carbopol® 934 proportion on nanoemulsion gel for topical and transdermal drug delivery: A skin permeation study. Int. J. Nanomed. 2016;11:5971.
Not in our library10.2147/ijn.s119286
159.
Wais M., Samad A., Nazish I., Khale A., Aqil M., Khan M. Formulation Development Ex-Vivo and in-Vivo Evaluation of Nanoemulsion for transdermal delivery of glibenclamide. Int. J. Pharm. Pharm. Sci. 2013;5:747-754.
Not in our library
160.
Sandig A.G., Campmany A.C., Campos F.F., Villena M.M., Naveros B.C. Transdermal delivery of imipramine and doxepin from newly oil-in-water nanoemulsions for an analgesic and anti-allodynic activity: Development, characterization and in vivo evaluation. Colloids Surf. B Biointerfaces. 2013;103:558-565.
Not in our library10.1016/j.colsurfb.2012.10.061
161.
Altamimi M., Haq N., Alshehri S., Qamar W., Shakeel F. Enhanced skin permeation of hydrocortisone using nanoemulsion as potential vehicle. ChemistrySelect. 2019;4:10084-10091.
Not in our library10.1002/slct.201902007
162.
Shaker D.S., Ishak R.A., Elhuoni M.A., Ghoneim A.M. Boosting transdermal delivery of atorvastatin calcium via o/w nanoemulsifying system: Two-step optimization, ex vivo and in vivo evaluation. Int. J. Pharm. 2020;578:119073.
Not in our library10.1016/j.ijpharm.2020.119073
163.
Abdulbaqi M.R., Rajab N. Apixaban Ultrafine O/W Nano Emulsion Transdermal Drug Delivery System: Formulation, In Vitro and Ex Vivo Characterization. Syst. Rev. Pharm. 2020;11:82-94.
Not in our library
164.
Campano-Cuevas E., Mora-Boza A., Castillo-Dalí G., RodríGuez-Gonzalez-Elipe A., Serrera-Figallo M.-A., Angel B., Torres-Lagares D. Nanotechnology in Medicine: Drug Delivery Systems. Drug Delivery Approaches and Nanosystems, Volume 1. 2017;55-93.
Not in our library
165.
Sunoqrot S., Hamed R., Abdel-Halim H., Tarawneh O. Synergistic Interplay of Medicinal Chemistry and Formulation Strategies in Nanotechnology—From Drug Discovery to Nanocarrier Design and Development. Curr. Top. Med. Chem. 2017;17:1451-1468.
Not in our library10.2174/1568026616666161222111656
166.
Ealias A.M., Saravanakumar M. A review on the classification, characterisation, synthesis of nanoparticles and their application. IOP Conf. Ser. Mater. Sci. Eng. 2017;263:032019.
Not in our library
167.
Ali A., Ahmed S. A review on chitosan and its nanocomposites in drug delivery. Int. J. Biol. Macromol. 2018;109:273-286.
Not in our library10.1016/j.ijbiomac.2017.12.078
168.
Tomoda K., Makino K., Ohshima H., Makino K. Chapter 7—Nanoparticles for transdermal drug delivery system (TDDS). Colloid and Interface Science in Pharmaceutical Research and Development. 2014;131-147.
Not in our library
169.
Nanoparticle-Enabled Transdermal Drug Delivery Systems for Enhanced Dose Control and Tissue Targeting · 2016
No notice
170.
Protein Nanoparticles as Drug Delivery Carriers for Cancer Therapy · 2014
No notice
171.
Valdivia-Olivares R.Y., Rodriguez-Fernandez M. The Importance of Nanocarrier Design and Composition for an Efficient Nanoparticle-Mediated Transdermal Vaccination. Vaccines. 2021;9:1420.
Not in our library10.3390/vaccines9121420
172.
Zhang K., Zhuang Y., Li J., Liu X., He S. Poly(Acrylic Acid)-Modified MoS2 Nanoparticle-Based Transdermal Delivery of Atenolol. Int. J. Nanomed. 2020;15:5517-5526.
Not in our library10.2147/ijn.s257906
173.
Zhao Q.H., Zhang Y., Liu Y., Wang H.L., Shen Y.Y., Yang W.J., Wen L.P. Anticancer effect of realgar nanoparticles on mouse melanoma skin cancer in vivo via transdermal drug delivery. Med. Oncol. 2010;27:203-212.
Not in our library10.1007/s12032-009-9192-1
174.
Sunoqrot S., Mahmoud N.N., Ibrahim L.H., Al-Dabash S., Raschke H., Hergenröder R. Tuning the Surface Chemistry of Melanin-Mimetic Polydopamine Nanoparticles Drastically Enhances Their Accumulation into Excised Human Skin. ACS Biomater. Sci. Eng. 2020;6:4424-4432.
Not in our library10.1021/acsbiomaterials.0c00196
175.
Al-Nemrawi N., Nimrawi S. A novel formulation of chitosan nanoparticles functionalized with titanium dioxide nanoparticles. J. Adv. Pharm. Technol. Res. 2021;12:402-407.
Not in our library10.4103/japtr.japtr_22_21
176.
Nabipour Z., Nourbakhsh M.S., Baniasadi M. Evaluation of ibuprofen release from gelatin/hydroxyapatite/polylactic acid nanocomposites. Iran. J. Pharm. Sci. 2018;14:75-84.
Not in our library
177.
Rasouli R., Barhoum A., Bechelany M., Dufresne A. Nanofibers for biomedical and healthcare applications. Macromol. Biosci. 2019;19:1800256.
Not in our library10.1002/mabi.201800256
178.
Astete C.E., Sabliov C.M. Synthesis and characterization of PLGA nanoparticles. J. Biomater. Sci. Polym. Ed. 2006;17:247-289.
Not in our library10.1163/156856206775997322
179.
Rancan F., Papakostas D., Hadam S., Hackbarth S., Delair T., Primard C., Verrier B., Sterry W., Blume-Peytavi U., Vogt A. Investigation of Polylactic Acid (PLA) Nanoparticles as Drug Delivery Systems for Local Dermatotherapy. Pharm. Res. 2009;26:2027-2036.
Not in our library10.1007/s11095-009-9919-x
180.
Li M.-C., Wu Q., Song K., Lee S., Qing Y., Wu Y. Cellulose Nanoparticles: Structure–Morphology–Rheology Relationships. ACS Sustain. Chem. Eng. 2015;3:821-832.
Not in our library10.1021/acssuschemeng.5b00144
181.
Vauthier C., Bouchemal K. Methods for the Preparation and Manufacture of Polymeric Nanoparticles. Pharm. Res. 2009;26:1025-1058.
Not in our library10.1007/s11095-008-9800-3
182.
Ho H.N., Le T.G., Dao T.T.T., Le T.H., Dinh T.T.H., Nguyen D.H., Tran T.C., Nguyen C.N. Development of Itraconazole-Loaded Polymeric Nanoparticle Dermal Gel for Enhanced Antifungal Efficacy. J. Nanomater. 2020;2020.
Not in our library10.1155/2020/8894541
183.
Jeong W.Y., Kim S., Lee S.Y., Lee H., Han D.W., Yang S.Y., Kim K.S. Transdermal delivery of Minoxidil using HA-PLGA nanoparticles for the treatment in alopecia. Biomater. Res. 2019;23:16.
Not in our library10.1186/s40824-019-0164-z
184.
Wang M., Marepally S., Vemula P., Xu C. Inorganic nanoparticles for transdermal drug delivery and topical application. Nanoscience in Dermatology. 2016;57-72.
Not in our library
185.
Abu-Huwaij R., Abbas M.M., Al-Shalabi R., Almasri F.N. Synthesis of transdermal patches loaded with greenly synthesized zinc oxide nanoparticles and their cytotoxic activity against triple negative breast cancer. Appl. Nanosci. 2022;12:69-78.
Not in our library10.1007/s13204-021-02166-y
186.
Naser R., Abu-Huwaij R., Al-khateeb I., Abbas M.M., Atoom A.M. Green synthesis of zinc oxide nanoparticles using the root hair extract of Phoenix dactylifera: Antimicrobial and anticancer activity. Appl. Nanosci. 2021;11:1747-1757.
Not in our library10.1007/s13204-021-01837-0
187.
Abu-Huwaij R., Al-Assaf S.F., Mousli F., Kutkut M.S., Al-Bashtawi A. Perceptive review on properties of iron oxide nanoparticles and their antimicrobial and anticancer activity. Sys. Rev. Pharm. 2020;11:418-431.
Not in our library
188.
Manivasagan P., Bharathiraja S., Moorthy M.S., Oh Y.-O., Seo H., Oh J. Marine biopolymer-based nanomaterials as a novel platform for theranostic applications. Polym. Rev. 2017;57:631-667.
Not in our library10.1080/15583724.2017.1311914
189.
Mahmoud N.N., Hamed R., Khalil E.A. Colloidal stability and rheological properties of gold nanoparticle–loaded polymeric hydrogels: Impact of nanoparticle’s shape, surface modification, and concentration. Colloid Polym. Sci. 2020;298:989-999.
Not in our library10.1007/s00396-020-04659-8
190.
Wang M., Marepally S.K., Vemula P.K., Xu C., Hamblin M.R., Avci P., Prow T.W. Chapter 5—Inorganic Nanoparticles for Transdermal Drug Delivery and Topical Application. Nanoscience in Dermatology. 2016;57-72.
Not in our library
191.
Labouta H.I., Schneider M. Interaction of inorganic nanoparticles with the skin barrier: Current status and critical review. Nanomed. Nanotechnol. Biol. Med. 2013;9:39-54.
Not in our library10.1016/j.nano.2012.04.004
192.
Mohamed A.L., Elmotasem H., Salama A.A.A. Colchicine mesoporous silica nanoparticles/hydrogel composite loaded cotton patches as a new encapsulator system for transdermal osteoarthritis management. Int. J. Biol. Macromol. 2020;164:1149-1163.
Not in our library10.1016/j.ijbiomac.2020.07.133
193.
Debnath S.K., Srivastava R. Drug Delivery With Carbon-Based Nanomaterials as Versatile Nanocarriers: Progress and Prospects. Front. Nanotechnol. 2021;3:644564.
Not in our library10.3389/fnano.2021.644564
194.
Strasinger C., Paudel K.S., Wu J., Hammell D., Pinninti R.R., Hinds B.J., Stinchcomb A. Programmable Transdermal Clonidine Delivery Through Voltage-Gated Carbon Nanotube Membranes. J. Pharm. Sci. 2014;103:1829-1838.
Not in our library10.1002/jps.23940
195.
Drug Solubility: Importance and Enhancement Techniques · 2012
No notice
196.
Vehring R. Pharmaceutical particle engineering via spray drying. Pharm. Res. 2008;25:999-1022.
Not in our library10.1007/s11095-007-9475-1
197.
Williams H.D., Trevaskis N.L., Charman S.A., Shanker R.M., Charman W.N., Pouton C.W., Porter C.J.H. Strategies to address low drug solubility in discovery and development. Pharmacol. Rev. 2013;65:315-499.
Not in our library10.1124/pr.112.005660
198.
Kolter K., Karl M., Gryczke A. Introduction to Solid Dispersions. In Hot-Melt Extrusion with BASF Pharma Polymers. 2012;9-18.
Not in our library
199.
Nanocrystals of Poorly Soluble Drugs: Drug Bioavailability and Physicochemical Stability · 2018
No notice
200.
Junghanns J.-U.A.H., Müller R.H. Nanocrystal technology, drug delivery and clinical applications. Int. J. Nanomed. 2008;3:295.
Not in our library10.2147/ijn.s595
201.
Chen L., Wang Y., Zhang J., Hao L., Guo H., Lou H., Zhang D. Bexarotene nanocrystal-Oral and parenteral formulation development, characterization and pharmacokinetic evaluation. Eur. J. Pharm. Biopharm. 2014;87:160-169.
Not in our library10.1016/j.ejpb.2013.12.005
202.
Colombo M., Staufenbiel S., Rühl E., Bodmeier R. In situ determination of the saturation solubility of nanocrystals of poorly soluble drugs for dermal application. Int. J. Pharm. 2017;521:156-166.
Not in our library10.1016/j.ijpharm.2017.02.030
203.
Ige P.P., Baria R.K., Gattani S.G. Fabrication of fenofibrate nanocrystals by probe sonication method for enhancement of dissolution rate and oral bioavailability. Colloids Surf. B Biointerfaces. 2013;108:366-373.
Not in our library10.1016/j.colsurfb.2013.02.043
204.
Liu C., Hu J., Sui H., Zhao Q., Zhang X., Wang W. Enhanced skin permeation of glabridin using eutectic mixture-based nanoemulsion. Drug Deliv. Transl. Res. 2017;7:325-332.
Not in our library10.1007/s13346-017-0359-6
205.
Fu Q., Sun J., Ai X., Zhang P., Li M., Wang Y., Liu X., Sun Y., Sui X., Sun L., et al. Nimodipine nanocrystals for oral bioavailability improvement: Role of mesenteric lymph transport in the oral absorption. Int. J. Pharm. 2013;448:290-297.
Not in our library10.1016/j.ijpharm.2013.01.065
206.
Mauludin R., Müller R.H., Keck C.M. Development of an oral rutin nanocrystal formulation. Int. J. Pharm. 2009;370:202-209.
Not in our library10.1016/j.ijpharm.2008.11.029
207.
Yu L. Amorphous pharmaceutical solids: Preparation, characterization and stabilization. Adv. Drug Deliv. Rev. 2001;48:27-42.
Not in our library10.1016/s0169-409x(01)00098-9
208.
Cerdeira A.M., Mazzotti M., Gander B. Miconazole nanosuspensions: Influence of formulation variables on particle size reduction and physical stability. Int. J. Pharm. 2010;396:210-218.
Not in our library10.1016/j.ijpharm.2010.06.020
209.
Mitri K., Shegokar R., Gohla S., Anselmi C., Müller R.H. Lutein nanocrystals as antioxidant formulation for oral and dermal delivery. Int. J. Pharm. 2011;420:141-146.
Not in our library10.1016/j.ijpharm.2011.08.026
210.
Müller R.H., Zhai X., Romero G.B., Keck C.M., Dragicevic N., Maibach H.I. Nanocrystals for Passive Dermal Penetration Enhancement. Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement: Nanocarriers. 2016;283-295.
Not in our library
211.
Parmar P.K., Wadhawan J., Bansal A.K. Pharmaceutical nanocrystals: A promising approach for improved topical drug delivery. Drug Discov. Today. 2021;26:2329-2349.
Not in our library10.1016/j.drudis.2021.07.010
212.
Zhou H., Luo D., Chen D., Tan X., Bai X., Liu Z., Yang X., Liu W. Current Advances of Nanocarrier Technology-Based Active Cosmetic Ingredients for Beauty Applications. Clin. Cosmet. Investig. Dermatol. 2021;14:867-887.
Not in our library10.2147/ccid.s313429
213.
Eckert R.W., Wiemann S., Keck C.M. Improved dermal and transdermal delivery of curcumin with smartfilms and nanocrystals. Molecules. 2021;26:1633.
Not in our library10.3390/molecules26061633
214.
Wadhawan J., Parmar P.K., Bansal A.K. Nanocrystals for improved topical delivery of medium soluble drug: A case study of acyclovir. J. Drug Deliv. Sci. Technol. 2021;65:102662.
Not in our library10.1016/j.jddst.2021.102662
215.
Khan B.A., Rashid F., Khan M.K., Alqahtani S.S., Sultan M.H., Almoshari Y. Fabrication of capsaicin loaded nanocrystals: Physical characterizations and in vivo evaluation. Pharmaceutics. 2021;13:841.
Not in our library10.3390/pharmaceutics13060841
216.
Localised and sustained intradermal delivery of methotrexate using nanocrystal-loaded microneedle arrays: Potential for enhanced treatment of psoriasis · 2020
No notice
217.
Avasatthi V., Pawar H., Dora C.P., Bansod P., Gill M.S., Suresh S. A novel nanogel formulation of methotrexate for topical treatment of psoriasis: Optimization, in vitro and in vivo evaluation. Pharm. Dev. Technol. 2016;21:554-562.
Not in our library10.3109/10837450.2015.1026605
218.
Parmar P.K., Bansal A.K. Novel nanocrystal-based formulations of apremilast for improved topical delivery. Drug Deliv. Transl. Res. 2021;11:966-983.
Not in our library10.1007/s13346-020-00809-1
219.
Kumar M., Shanthi N., Mahato A.K., Soni S., Rajnikanth P.S. Preparation of luliconazole nanocrystals loaded hydrogel for improvement of dissolution and antifungal activity. Heliyon. 2019;5:e01688.
Not in our library10.1016/j.heliyon.2019.e01688
220.
Döge N., Hönzke S., Schumacher F., Balzus B., Colombo M., Hadam S., Rancan F., Blume-Peytavi U., Schäfer-Korting M., Schindler A., et al. Ethyl cellulose nanocarriers and nanocrystals differentially deliver dexamethasone into intact, tape-stripped or sodium lauryl sulfate-exposed ex vivo human skin—Assessment by intradermal microdialysis and extraction from the different skin layers. J. Control. Release. 2016;242:25-34.
Not in our library10.1016/j.jconrel.2016.07.009
221.
Wang W.P., Hul J., Sui H., Zhao Y.S., Feng J., Liu C. Glabridin nanosuspension for enhanced skin penetration: Formulation optimization, in vitro and in vivo evaluation. Pharmazie. 2016;71:252-257.
Not in our library
222.
Assem M., Khowessah O.M., Ghorab D. Nano-crystallization as a tool for the enhancement of beclomethasone dipropionate dermal deposition: Formulation, in vitro characterization and ex vivo study. J. Drug Deliv. Sci. Technol. 2019;54:101318.
Not in our library10.1016/j.jddst.2019.101318
223.
Oktay A.N., Ilbasmis-Tamer S., Han S., Uludag O., Celebi N. Preparation and in vitro/in vivo evaluation of flurbiprofen nanosuspension-based gel for dermal application. Eur. J. Pharm. Sci. Off. J. Eur. Fed. Pharm. Sci. 2020;155:105548.
Not in our library10.1016/j.ejps.2020.105548
224.
Abdelghany S., Tekko I.A., Vora L., Larrañeta E., Permana A.D., Donnelly R.F. Nanosuspension-based dissolving microneedle arrays for intradermal delivery of curcumin. Pharmaceutics. 2019;11:308.
Not in our library10.3390/pharmaceutics11070308
225.
Hamed R., Mohamed E.M., Sediri K., Khan M.A., Rahman Z. Development of stable amorphous solid dispersion and quantification of crystalline fraction of lopinavir by spectroscopic-chemometric methods. Int. J. Pharm. 2021;602:120657.
Not in our library10.1016/j.ijpharm.2021.120657
226.
Chiou W.L., Riegelman S. Pharmaceutical applications of solid dispersion systems. J. Pharm. Sci. 1971;60:1281-1302.
Not in our library10.1002/jps.2600600902
227.
Zhao M., Barker S.A., Belton P.S., McGregor C., Craig D.Q.M. Development of fully amorphous dispersions of a low Tg drug via co-spray drying with hydrophilic polymers. Eur. J. Pharm. Biopharm. 2012;82:572-579.
Not in our library10.1016/j.ejpb.2012.07.012
228.
Alhijjaj M., Belton P., Qi S. An investigation into the use of polymer blends to improve the printability of and regulate drug release from pharmaceutical solid dispersions prepared via fused deposition modeling (FDM) 3D printing. Eur. J. Pharm. Biopharm. 2016;108:111-125.
Not in our library10.1016/j.ejpb.2016.08.016
229.
Brough C., Williams R.O. Amorphous solid dispersions and nano-crystal technologies for poorly water-soluble drug delivery. Int. J. Pharm. 2013;453:157-166.
Not in our library10.1016/j.ijpharm.2013.05.061
230.
Friesen D.T., Shanker R., Crew M., Smithey D.T., Curatolo W.J., Nightingale J.A.S. Hydroxypropyl methylcellulose acetate succinate-based spray-dried dispersions: An overview. Mol. Pharm. 2008;5:1003-1019.
Not in our library10.1021/mp8000793
231.
Fundamental aspects of solid dispersion technology for poorly soluble drugs · 2014
Not checked
232.
Sarode A.L., Sandhu H., Shah N., Malick W., Zia H. Hot melt extrusion (HME) for amorphous solid dispersions: Predictive tools for processing and impact of drug-polymer interactions on supersaturation. Eur. J. Pharm. Sci. 2013;48:371-384.
Not in our library10.1016/j.ejps.2012.12.012
233.
Obaidat R.M., Khanfar M., Ghanma R. A Comparative Solubility Enhancement Study of Cefixime Trihydrate Using Different Dispersion Techniques. AAPS PharmSciTech. 2019;20:194.
Not in our library10.1208/s12249-019-1395-y
234.
Gato K., Fujii M.Y., Hisada H., Carriere J., Koide T., Fukami T. Molecular state evaluation of active pharmaceutical ingredients in adhesive patches for transdermal drug delivery. J. Drug Deliv. Sci. Technol. 2020;58:101800.
Not in our library10.1016/j.jddst.2020.101800
235.
Jermain S.V., Brough C., Williams R.O. Amorphous solid dispersions and nanocrystal technologies for poorly water-soluble drug delivery—An update. Int. J. Pharm. 2018;535:379-392.
Not in our library10.1016/j.ijpharm.2017.10.051
236.
Peltonen L., Strachan C.J. Degrees of order: A comparison of nanocrystal and amorphous solids for poorly soluble drugs. Int. J. Pharm. 2020;586:119492.
Not in our library10.1016/j.ijpharm.2020.119492
237.
Yani F., Arianto A., Noersal R. Formulation of Ketoprofen Transdermal Solid Dispersion Patch as an Analgesic and Anti-Inflammatory. Asian J. Pharm. Res. Dev. 2020;8:51-58.
Not in our library10.22270/ajprd.v8i3.760
238.
Marreto R.N., Cardoso G., dos Santos Souza B., Martin-Pastor M., Cunha-Filho M., Taveira S.F., Concheiro A., Alvarez-Lorenzo C. Hot melt-extrusion improves the properties of cyclodextrin-based poly(pseudo)rotaxanes for transdermal formulation. Int. J. Pharm. 2020;586:119510.
Not in our library10.1016/j.ijpharm.2020.119510
239.
Azizoğlu E., Özer Ö. Fabrication of Montelukast sodium loaded filaments and 3D printing transdermal patches onto packaging material. Int. J. Pharm. 2020;587:119588.
Not in our library10.1016/j.ijpharm.2020.119588
240.
Chaudhari V.S., Malakar T.K., Murty U.S., Banerjee S. Extruded filaments derived 3D printed medicated skin patch to mitigate destructive pulmonary tuberculosis: Design to delivery. Expert Opin. Drug Deliv. 2021;18:301-313.
Not in our library10.1080/17425247.2021.1845648
241.
Bhardwaj S., Bhatia S., Singh S. Transdermal Delivery of Ondansetron Hydrochloride in the management of Hyperemesis Gravidarum. Int. J. Pharm. Sci. Res. 2020;11:206-214.
Not in our library
242.
Soral M., Nanjappa S.H., Alayadan P. Formulation and evaluation of transdermal patch of rabeprazole sodium. J. Rep. Pharm. Sci. 2021;10:240.
Not in our library10.4103/jrptps.jrptps_126_20
243.
Lakshmi S.S., Rao Y.S., Asha D., Kumari P.K., Mallikarjun P. Formulation and evaluation of rosuvastatin-calcium drug transdermal patch. Res. J. Pharm. Technol. 2020;13:4784-4790.
Not in our library10.5958/0974-360x.2020.00841.0
244.
Parhi R., Suresh P., Patnaik S. Physical means of stratum corneum barrier manipulation to enhance transdermal drug delivery. Curr. Drug Deliv. 2015;12:122-138.
Not in our library10.2174/1567201811666140515145329
245.
Abd-Elghany A.A., Mohamad E.A. Ex-vivo transdermal delivery of Annona squamosa entrapped in niosomes by electroporation. J. Radiat. Res. Appl. Sci. 2020;13:164-173.
Not in our library10.1080/16878507.2020.1719329
246.
Anantrao J.H., Nath P.A., Nivrutti P.R. Drug Penetration Enhancement Techniques in Transdermal Drug Delivery System: A Review. J. Pharm. Res. Int. 2021;46-61.
Not in our library10.9734/jpri/2021/v33i19b31337
247.
Ita K. Perspectives on transdermal electroporation. Pharmaceutics. 2016;8:9.
Not in our library10.3390/pharmaceutics8010009
248.
Demiryurek Y., Nickaeen M., Zheng M., Yu M., Zahn J.D., Shreiber D.I., Lin H., Shan J.W. Transport, resealing, and re-poration dynamics of two-pulse electroporation-mediated molecular delivery. Acta (BBA)-Biomembr. 2015;1848:1706-1714.
Not in our library10.1016/j.bbamem.2015.04.007
249.
Wang Y., Zeng L., Song W., Liu J. Influencing factors and drug application of iontophoresis in transdermal drug delivery: An overview of recent progress. Drug Deliv. Transl. Res. 2021;12:15-26.
Not in our library10.1007/s13346-021-00898-6
250.
Ita K. Percutaneous transport of psychotropic agents. J. Drug Deliv. Sci. Technol. 2017;39:247-259.
Not in our library10.1016/j.jddst.2017.04.009
251.
Petrilli R., Lopez R.F.V. Physical methods for topical skin drug delivery: Concepts and applications. Braz. J. Pharm. Sci. 2018;54.
Not in our library10.1590/s2175-97902018000001008
252.
Dixit N., Bali V., Baboota S., Ahuja A., Ali J. Iontophoresis-an approach for controlled drug delivery: A review. Curr. Drug Deliv. 2007;4:1-10.
Not in our library10.2174/1567201810704010001
253.
Pikal M.J. The role of electroosmotic flow in transdermal iontophoresis. Adv. Drug Deliv. Rev. 2001;46:281-305.
Not in our library10.1016/s0169-409x(00)00138-1
254.
Dhote V., Bhatnagar P., Mishra P.K., Mahajan S.C., Mishra D.K. Iontophoresis: A potential emergence of a transdermal drug delivery system. Sci. Pharm. 2012;80:1-28.
Not in our library10.3797/scipharm.1108-20
255.
Saepang K., Li S.K., Chantasart D. Effect of pH on iontophoretic transport of pramipexole dihydrochloride across human epidermal membrane. Pharm. Res. 2021;38:657-668.
Not in our library10.1007/s11095-021-03001-3
256.
Monti D., Egiziano E., Burgalassi S., Tampucci S., Terreni E., Tivegna S., Chetoni P. Influence of a combination of chemical enhancers and iontophoresis on in vitro transungual permeation of nystatin. AAPS PharmSciTech. 2018;19:1574-1581.
Not in our library10.1208/s12249-018-0977-4
257.
Giri T.K., Chakrabarty S., Ghosh B.J.C.P.A. Non-Invasive Extraction of Gabapentin for Therapeutic Drug Monitoring by Reverse Iontophoresis: Effect of pH, Ionic Strength, and Polyethylene Glycol 400 in the Receiving Medium. Curr. Pharm. Anal. 2019;15:632-639.
Not in our library10.2174/1573412914666180910115059
258.
Azad Khan M.Y., Asif M., Chauhan I., Singh A.P., Sharma R., Singh P., Rai S.J. Iontophoretic drug delivery: History and applications. J. Ocul. Pharmacol. Ther. 2011;1:11-24.
Not in our library
259.
Chen K., Puri V., Michniak-Kohn B. Iontophoresis to Overcome the Challenge of Nail Permeation: Considerations and Optimizations for Successful Ungual Drug Delivery. AAPS J. 2021;23:1-15.
Not in our library10.1208/s12248-020-00552-y
260.
Banga A.K. Electrically Assisted Transdermal and Topical Drug Delivery. 1998.
Not in our library
261.
Michov B. 4 Iontophoresis. Electrophoresis. 2020;739-752.
Not in our library
262.
Perez V.L., Wirostko B., Korenfeld M., From S., Raizman M. Ophthalmic drug delivery using iontophoresis: Recent clinical applications. J. Ocul. Pharmacol. 2020;36:75-87.
Not in our library10.1089/jop.2019.0034
263.
Schoellhammer C.M., Blankschtein D., Langer R. Skin permeabilization for transdermal drug delivery: Recent advances and future prospects. Expert Opin. Drug Deliv. 2014;11:393-407.
Not in our library10.1517/17425247.2014.875528
264.
Krishnan G., Roberts M.S., Grice J., Anissimov Y.G., Moghimi H.R., Benson H.A. Iontophoretic skin permeation of peptides: An investigation into the influence of molecular properties, iontophoretic conditions and formulation parameters. Drug Deliv. Transl. Res. 2014;4:222-232.
Not in our library10.1007/s13346-013-0181-8
265.
Karpiński T.M. Selected medicines used in iontophoresis. Pharmaceutics. 2018;10:204.
Not in our library10.3390/pharmaceutics10040204
266.
Fatima T., Ajjarapu S., Shankar V.K., Rangappa S., Shivakumar H.N., Biswas S.K., Hoque M., Murthy S. Topical pilocarpine formulation for diagnosis of cystic fibrosis. J. Pharm. Sci. 2020;109:1747-1751.
Not in our library10.1016/j.xphs.2020.01.030
267.
Yengin C., Kilinc E., Der F.G., Sezgin M.C., Alcin I. Optimization of Extraction Parameters of Reverse Iontophoretic Determination of Blood Glucose in an Artificial Skin Model. Curr. Anal. Chem. 2020;16:722-737.
Not in our library10.2174/1573411015666190710232858
268.
Lemke J., Sardariani E., Phipps J.B., Patel N., Itri L.M., Caravelli J., Viscusi E.R. Fentanyl Iontophoretic Transdermal System (IONSYS®) can be Safely used in the Hospital Environment with X-Rays, Computerized Tomography and Radiofrequency Identification Devices. Adv. Ther. 2016;33:1649-1659.
Not in our library10.1007/s12325-016-0381-y
269.
Vikelis M., Mitsikostas D.D., Rapoport A.M. Sumatriptan iontophoretic transdermal system for the acute treatment of migraine. Pain Manag. 2014;4:123-128.
Not in our library10.2217/pmt.13.71
270.
Scott J.A., Banga A.K. Cosmetic devices based on active transdermal technologies. Ther. Deliv. 2015;6:1089-1099.
Not in our library10.4155/tde.15.64
271.
Roustit M., Blaise S., Cracowski J.L. Trials and tribulations of skin iontophoresis in therapeutics. Br. J. Clin. Pharmacol. 2014;77:63-71.
Not in our library10.1111/bcp.12128
272.
Wang R., Bian Q., Xu Y., Xu D., Gao J. Recent advances in mechanical force-assisted transdermal delivery of macromolecular drugs. Int. J. Pharm. 2021;602:120598.
Not in our library10.1016/j.ijpharm.2021.120598
273.
Marwah H., Garg T., Goyal A.K., Rath G. Permeation enhancer strategies in transdermal drug delivery. Drug Deliv. 2016;23:564-578.
Not in our library10.3109/10717544.2014.935532
274.
Miyazaki H., Atobe S., Suzuki T., Iga H., Terai K. Development of pyro-drive jet injector with controllable jet pressure. J. Pharm. Sci. 2019;108:2415-2420.
Not in our library10.1016/j.xphs.2019.02.021
275.
Arora A. Liquid and powder jet injectors in drug delivery: Mechanisms, designs, and applications. Percutaneous Penetration Enhancers Physical Methods in Penetration Enhancement. 2017;221-230.
Not in our library
276.
Mitragotri S. Current status and future prospects of needle-free liquid jet injectors. Nat. Rev. Drug Discov. 2006;5:543-548.
Not in our library10.1038/nrd2076
277.
Needle free injection technology - An overview · 2014
Not checked
278.
Trimzi M.A., Ham Y.-B. A Needle-Free Jet Injection System for Controlled Release and Repeated Biopharmaceutical Delivery. Pharmaceutics. 2021;13:1770.
Not in our library10.3390/pharmaceutics13111770
279.
Kendall M., Mitchell T., Wrighton-Smith P. Intradermal ballistic delivery of micro-particles into excised human skin for pharmaceutical applications. J. Biomech. 2004;37:1733-1741.
Not in our library10.1016/j.jbiomech.2004.01.032
280.
Mulholland W.J., Kendall M.A., White N., Bellhouse B.J. Characterization of powdered epidermal vaccine delivery with multiphoton microscopy. Phys. Med. Biol. 2004;49:5043.
Not in our library10.1088/0031-9155/49/22/002
281.
Mathur V., Satrawala Y., Rajput M.S. Physical and chemical penetration enhancers in transdermal drug delivery system. Asian J. Pharm. (AJP). 2014;4.
Not in our library10.4103/0973-8398.72115
282.
Khan S., Hasan A., Attar F., Babadaei M.M.N., Zeinabad H.A., Salehi M., Alizadeh M., Hassan M., Derakhshankhah H., Hamblin M.R., et al. Diagnostic and drug release systems based on microneedle arrays in breast cancer therapy. J. Control. Release. 2021;338:341-357.
Not in our library10.1016/j.jconrel.2021.08.036
283.
Nagarkar R., Singh M., Nguyen H.X., Jonnalagadda S. A review of recent advances in microneedle technology for transdermal drug delivery. J. Drug Deliv. Sci. Technol. 2020;59:101923.
Not in our library10.1016/j.jddst.2020.101923
284.
Obaidat R., BaniAmer F., Assaf S.M., Yassin A. Fabrication and Evaluation of Transdermal Delivery of Carbamazepine Dissolving Microneedles. AAPS PharmSciTech. 2021;22:253.
Not in our library10.1208/s12249-021-02136-1
285.
Chevala N.T., Jitta S.R., Marques S.M., Vaz V.M., Kumar L. Polymeric microneedles for transdermal delivery of nanoparticles: Frontiers of formulation, sterility and stability aspects. J. Drug Deliv. Sci. Technol. 2021;65:102711.
Not in our library
286.
Yang D., Chen M., Sun Y., Jin Y., Lu C., Pan X., Quan G., Wu C. Microneedle-mediated transdermal drug delivery for treating diverse skin diseases. Acta Biomater. 2020;121:119-133.
Not in our library10.1016/j.actbio.2020.12.004
287.
Singh T.R.R., McMillan H., Mooney K., Alkilani A.Z., Donnelly R.F., Dragicevic N., Maibach H.I. Fabrication of Microneedles. Percutaneous Penetration Enhancers Physical Methods in Penetration Enhancement. 2017;305-323.
Not in our library
288.
Ingrole R.S.J., Azizoglu E., Dul M., Birchall J.C., Gill H.S., Prausnitz M.R. Trends of microneedle technology in the scientific literature, patents, clinical trials and internet activity. Biomaterials. 2021;267:120491.
Not in our library10.1016/j.biomaterials.2020.120491
289.
Yang J., Zhang H., Hu T., Xu C., Jiang L., Shrike Zhang Y., Xie M. Recent advances of microneedles used towards stimuli-responsive drug delivery, disease theranostics, and bioinspired applications. Chem. Eng. J. 2021;426:130561.
Not in our library10.1016/j.cej.2021.130561
290.
Design and physicochemical characterisation of novel dissolving polymeric microneedle arrays for transdermal delivery of high dose, low molecular weight drugs · 2014
No notice
291.
Kearney M.-C., Caffarel-Salvador E., Fallows S.J., McCarthy H.O., Donnelly R.F. Microneedle-mediated delivery of donepezil: Potential for improved treatment options in Alzheimer’s disease. Eur. J. Pharm. Biopharm. 2016;103:43-50.
Not in our library10.1016/j.ejpb.2016.03.026
292.
Zhang L.Q., Zhang X.P., Hao Y.Y., Zhang B.L., Guo X.D. Codelivery of hydrophilic and hydrophobic drugs in a microneedle patch for the treatment of skin pigmentation. J. Ind. Eng. Chem. 2020;88:241-250.
Not in our library10.1016/j.jiec.2020.04.019
293.
Oh J.-H., Park H.-H., Do K.-Y., Han M., Hyun D.-H., Kim C.-G., Kim C.-H., Lee S.S., Hwang S.-J., Shin S.-C., et al. Influence of the delivery systems using a microneedle array on the permeation of a hydrophilic molecule, calcein. Eur. J. Pharm. Biopharm. 2008;69:1040-1045.
Not in our library10.1016/j.ejpb.2008.02.009
294.
Chen X., Wang L., Yu H., Li C., Feng J., Haq F., Khan A., Khan R.U. Preparation, properties and challenges of the microneedles-based insulin delivery system. J. Control. Release. 2018;288:173-188.
Not in our library10.1016/j.jconrel.2018.08.042
295.
Yu W., Jiang G., Liu D., Li L., Tong Z., Yao J., Kong X. Transdermal delivery of insulin with bioceramic composite microneedles fabricated by gelatin and hydroxyapatite. Mater. Sci. Eng. C. 2017;73:425-428.
Not in our library10.1016/j.msec.2016.12.111
296.
Stinson J.A., Boopathy A.V., Cieslewicz B.M., Zhang Y., Hartman N.W., Miller D.P., Dirckx M., Hurst B.L., Tarbet E.B., Kluge J.A., et al. Enhancing influenza vaccine immunogenicity and efficacy through infection mimicry using silk microneedles. Vaccine. 2021;39:5410-5421.
Not in our library10.1016/j.vaccine.2021.07.064
297.
Liu T., Chen M., Fu J., Sun Y., Lu C., Quan G., Pan X., Wu C. Recent advances in microneedles-mediated transdermal delivery of protein and peptide drugs. Acta Pharm. Sin. B. 2021;11:2326-2343.
Not in our library10.1016/j.apsb.2021.03.003
298.
Choi S.Y., Kwon H.J. Hyaluronic acid microneedle patch for the improvement of crow’s feet wrinkles. Dermatol. Ther. 2017;30:e12546.
Not in our library10.1111/dth.12546
299.
Microneedle enhanced delivery of cosmeceutically relevant peptides in human skin. · 2014
Not checked
300.
Park Y., Park J., Chu G.S., Kim K.S., Sung J.H., Kim B. Transdermal delivery of cosmetic ingredients using dissolving polymer microneedle arrays. Biotechnol. Bioprocess Eng. 2015;20:543-549.
Not in our library10.1007/s12257-014-0775-0
301.
Peng K., Vora L.K., Tekko I.A., Permana A.D., Domínguez-Robles J., Ramadon D., Chambers P., McCarthy H.O., Larrañeta E., Donnelly R.F. Dissolving microneedle patches loaded with amphotericin B microparticles for localised and sustained intradermal delivery: Potential for enhanced treatment of cutaneous fungal infections. J. Control. Release. 2021;339:361-380.
Not in our library10.1016/j.jconrel.2021.10.001
302.
Zhang D., Das D.B., Rielly C.D. An Experimental Study of Microneedle-Assisted Microparticle Delivery. J. Pharm. Sci. 2013;102:3632-3644.
Not in our library10.1002/jps.23665
303.
Ilić T., Savić S., Batinić B., Marković B., Schmidberger M., Lunter D., Savić M., Savić S. Combined use of biocompatible nanoemulsions and solid microneedles to improve transport of a model NSAID across the skin: In vitro and in vivo studies. Eur. J. Pharm. Sci. 2018;125:110-119.
Not in our library10.1016/j.ejps.2018.09.023
304.
Yin Y., Su W., Zhang J., Huang W., Li X., Ma H., Tan M., Song H., Cao G., Yu S., et al. Separable Microneedle Patch to Protect and Deliver DNA Nanovaccines Against COVID-19. ACS Nano. 2021;15:14347-14359.
Not in our library10.1021/acsnano.1c03252
305.
Niu L., Chu L.Y., Burton S.A., Hansen K.J., Panyam J. Intradermal delivery of vaccine nanoparticles using hollow microneedle array generates enhanced and balanced immune response. J. Control. Release. 2019;294:268-278.
Not in our library10.1016/j.jconrel.2018.12.026
306.
Larrañeta E., Lutton R.E.M., Woolfson A.D., Donnelly R.F. Microneedle arrays as transdermal and intradermal drug delivery systems: Materials science, manufacture and commercial development. Mater. Sci. Eng. R Rep. 2016;104:1-32.
Not in our library10.1016/j.mser.2016.03.001
307.
Haq M.I., Smith E., John D.N., Kalavala M., Edwards C., Anstey A., Morrissey A., Birchall J.C. Clinical administration of microneedles: Skin puncture, pain and sensation. Biomed. Microdevices. 2009;11:35-47.
Not in our library10.1007/s10544-008-9208-1
308.
Tran K.T.M., Gavitt T.D., Farrell N.J., Curry E.J., Mara A.B., Patel A., Brown L., Kilpatrick S., Piotrowska R., Mishra N., et al. Transdermal microneedles for the programmable burst release of multiple vaccine payloads. Nat. Biomed. Eng. 2021;5:998-1007.
Not in our library10.1038/s41551-020-00650-4
309.
Kathuria H., Lim D., Cai J., Chung B.G. Microneedles with Tunable Dissolution Rate. ACS Biomater. Sci. Eng. 2020;6:5061-5068.
Not in our library10.1021/acsbiomaterials.0c00759
310.
Alhnan M.A., Okwuosa T.C., Sadia M., Wan K.W., Ahmed W., Arafat B. Emergence of 3D Printed Dosage Forms: Opportunities and Challenges. Pharm. Res. 2016;33:1817-1832.
Not in our library10.1007/s11095-016-1933-1
311.
3D-printed microneedles in biomedical applications · 2021
Not checked
312.
Pere C.P.P., Economidou S.N., Lall G., Ziraud C., Boateng J.S., Alexander B.D., Lamprou D.A., Douroumis D. 3D printed microneedles for insulin skin delivery. Int. J. Pharm. 2018;544:425-432.
Not in our library10.1016/j.ijpharm.2018.03.031
313.
Economidou S.N., Uddin M.J., Marques M.J., Douroumis D., Sow W.T., Li H., Reid A., Windmill J.F.C., Podoleanu A. A novel 3D printed hollow microneedle microelectromechanical system for controlled, personalized transdermal drug delivery. Addit. Manuf. 2021;38:101815.
Not in our library10.1016/j.addma.2020.101815
314.
Caudill C., Perry J.L. Transdermal vaccination via 3D-printed microneedles induces potent humoral and cellular immunity. Proc. Natl. Acad. Sci. USA. 2021;118.
Not in our library10.1073/pnas.2102595118
315.
Economidou S.N., Pissinato Pere C.P., Okereke M., Douroumis D. Optimisation of Design and Manufacturing Parameters of 3D Printed Solid Microneedles for Improved Strength, Sharpness, and Drug Delivery. Micromachines. 2021;12:117.
Not in our library10.3390/mi12020117
316.
Elahpour N., Pahlevanzadeh F., Kharaziha M., Bakhsheshi-Rad H.R., Ramakrishna S., Berto F. 3D printed microneedles for transdermal drug delivery: A brief review of two decades. Int. J. Pharm. 2021;597:120301.
Not in our library10.1016/j.ijpharm.2021.120301
317.
Liu T., Luo G., Xing M. Biomedical applications of polymeric microneedles for transdermal therapeutic delivery and diagnosis: Current status and future perspectives. Adv. Ther. 2020;3:1900140.
Not in our library10.1002/adtp.201900140
318.
Szeto B., Aksit A., Valentini C., Yu M., Werth E.G., Goeta S., Tang C., Brown L.M., Olson E.S., Kysar J.W., et al. Novel 3D-printed hollow microneedles facilitate safe, reliable, and informative sampling of perilymph from guinea pigs. Hear. Res. 2021;400:108141.
Not in our library10.1016/j.heares.2020.108141
319.
Yang Q., Zhong W., Xu L., Li H., Yan Q., She Y., Yang G. Recent progress of 3D-printed microneedles for transdermal drug delivery. Int. J. Pharm. 2021;593:120106.
Not in our library10.1016/j.ijpharm.2020.120106
320.
Waghule T., Singhvi G., Dubey S.K., Pandey M.M., Gupta G., Singh M., Dua K. Microneedles: A smart approach and increasing potential for transdermal drug delivery system. Biomed. Pharmacother. 2019;109:1249-1258.
Not in our library10.1016/j.biopha.2018.10.078
321.
Biospace.
Not in our library
322.
Jeong H.R., Jun H., Cha H.R., Lee J.M., Park J.H. Safe coated microneedles with reduced puncture occurrence after administration. Micromachines. 2020;11:710.
Not in our library10.3390/mi11080710
323.
Kapoor Y., Milewski M., Dick L., Zhang J., Bothe J.R., Gehrt M., Manser K., Nissley B., Petrescu I., Johnson P., et al. Coated microneedles for transdermal delivery of a potent pharmaceutical peptide. Biomed. Microdevices. 2020;22:7.
Not in our library10.1007/s10544-019-0462-1
324.
Liang L., Chen Y., Zhang B.L., Zhang X.P., Liu J.L., Shen C.B., Cui Y., Guo X.D. Optimization of dip-coating methods for the fabrication of coated microneedles for drug delivery. J. Drug Deliv. Sci. Technol. 2020;55:101464.
Not in our library10.1016/j.jddst.2019.101464
325.
Chang H., Zheng M., Chew S.W.T., Xu C. Advances in the Formulations of Microneedles for Manifold Biomedical Applications. Advanced Materials Technologies. 2020;Volume 5.
Not in our library
326.
Moussi K., Bukhamsin A., Hidalgo T., Kosel J. Biocompatible 3D printed microneedles for transdermal, intradermal, and percutaneous applications. Adv. Eng. Mater. 2020;22:1901358.
Not in our library10.1002/adem.201901358
327.
Sachan A., Sachan R.J., Lu J., Sun H., Jin Y.J., Erdmann D., Zhang J.Y., Narayan R.J. Injection molding for manufacturing of solid poly(l-lactide-co-glycolide) microneedles. MRS Adv. 2021;6:61-65.
Not in our library10.1557/s43580-021-00030-3
328.
Turner J.G., White L.R., Estrela P., Leese H.S. Hydrogel-Forming Microneedles: Current Advancements and Future Trends. Macromolecular Bioscience. 2021;Volume 21.
Not in our library10.1002/mabi.202000307
329.
Hydrogel-Forming Microneedles Prepared from “Super Swelling” Polymers Combined with Lyophilised Wafers for Transdermal Drug Delivery · 2014
No notice
330.
ClinicalTrials.gov. ClinicalTrials.gov Is a Resource Provided by the U.S. National Library of Medicine.
Not in our library
331.
Roep B.O., Wheeler D.C.S., Peakman M. Antigen-based immune modulation therapy for type 1 diabetes: The era of precision medicine. Lancet. Diabetes Endocrinol. 2019;7:65-74.
Not in our library10.1016/s2213-8587(18)30109-8
332.
Alimardani V., Abolmaali S.S., Yousefi G., Rahiminezhad Z., Abedi M. Microneedle Arrays Combined with Nanomedicine Approaches for Transdermal Delivery of Therapeutics. J. Clin. Med. 2021;10:181.
Not in our library10.3390/jcm10020181

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.